nodes	percent_of_prediction	percent_of_DWPC	metapath
Terazosin—ABCB1—ovarian cancer	0.576	1	CbGaD
Terazosin—ABCB1—Topotecan—ovarian cancer	0.0533	0.354	CbGbCtD
Terazosin—ABCB1—Vinorelbine—ovarian cancer	0.0375	0.249	CbGbCtD
Terazosin—ABCB1—Paclitaxel—ovarian cancer	0.0264	0.175	CbGbCtD
Terazosin—ABCB1—Docetaxel—ovarian cancer	0.0191	0.127	CbGbCtD
Terazosin—ABCB1—Doxorubicin—ovarian cancer	0.0142	0.0945	CbGbCtD
Terazosin—KCNH7—testis—ovarian cancer	0.00231	0.109	CbGeAlD
Terazosin—KCNH6—uterus—ovarian cancer	0.00227	0.107	CbGeAlD
Terazosin—KCNH6—female reproductive system—ovarian cancer	0.00204	0.0966	CbGeAlD
Terazosin—ADRA1D—epithelium—ovarian cancer	0.00152	0.072	CbGeAlD
Terazosin—ADRA1D—female reproductive system—ovarian cancer	0.00113	0.0535	CbGeAlD
Terazosin—KCNH2—myometrium—ovarian cancer	0.00108	0.0509	CbGeAlD
Terazosin—Doxazosin—ABCB1—ovarian cancer	0.000909	0.52	CrCbGaD
Terazosin—ADRA1A—epithelium—ovarian cancer	0.000874	0.0414	CbGeAlD
Terazosin—Prazosin—ABCB1—ovarian cancer	0.000838	0.479	CrCbGaD
Terazosin—KCNH2—uterine cervix—ovarian cancer	0.000837	0.0396	CbGeAlD
Terazosin—KCNH2—endometrium—ovarian cancer	0.000757	0.0358	CbGeAlD
Terazosin—KCNH2—uterus—ovarian cancer	0.000697	0.033	CbGeAlD
Terazosin—KCNH2—female reproductive system—ovarian cancer	0.000627	0.0297	CbGeAlD
Terazosin—KCNH2—bone marrow—ovarian cancer	0.000592	0.028	CbGeAlD
Terazosin—KCNH2—female gonad—ovarian cancer	0.00057	0.027	CbGeAlD
Terazosin—KCNH2—vagina—ovarian cancer	0.000567	0.0268	CbGeAlD
Terazosin—KCNH2—testis—ovarian cancer	0.000506	0.024	CbGeAlD
Terazosin—ABCB1—myometrium—ovarian cancer	0.000472	0.0223	CbGeAlD
Terazosin—ABCB1—embryo—ovarian cancer	0.000454	0.0215	CbGeAlD
Terazosin—Pruritus—Vinorelbine—ovarian cancer	0.000431	0.00172	CcSEcCtD
Terazosin—Arthralgia—Paclitaxel—ovarian cancer	0.000428	0.0017	CcSEcCtD
Terazosin—Chest pain—Paclitaxel—ovarian cancer	0.000428	0.0017	CcSEcCtD
Terazosin—Myalgia—Paclitaxel—ovarian cancer	0.000428	0.0017	CcSEcCtD
Terazosin—Nasopharyngitis—Epirubicin—ovarian cancer	0.000426	0.0017	CcSEcCtD
Terazosin—Anxiety—Paclitaxel—ovarian cancer	0.000426	0.0017	CcSEcCtD
Terazosin—Face oedema—Doxorubicin—ovarian cancer	0.000426	0.0017	CcSEcCtD
Terazosin—Malnutrition—Docetaxel—ovarian cancer	0.000426	0.0017	CcSEcCtD
Terazosin—Nausea—Topotecan—ovarian cancer	0.000423	0.00169	CcSEcCtD
Terazosin—Discomfort—Paclitaxel—ovarian cancer	0.000423	0.00168	CcSEcCtD
Terazosin—Gastritis—Epirubicin—ovarian cancer	0.000422	0.00168	CcSEcCtD
Terazosin—Dry mouth—Paclitaxel—ovarian cancer	0.000418	0.00167	CcSEcCtD
Terazosin—Diarrhoea—Vinorelbine—ovarian cancer	0.000417	0.00166	CcSEcCtD
Terazosin—Dysgeusia—Docetaxel—ovarian cancer	0.000417	0.00166	CcSEcCtD
Terazosin—Nausea—Melphalan—ovarian cancer	0.000414	0.00165	CcSEcCtD
Terazosin—Confusional state—Paclitaxel—ovarian cancer	0.000413	0.00165	CcSEcCtD
Terazosin—Asthma—Epirubicin—ovarian cancer	0.000412	0.00164	CcSEcCtD
Terazosin—Influenza—Epirubicin—ovarian cancer	0.000412	0.00164	CcSEcCtD
Terazosin—Back pain—Docetaxel—ovarian cancer	0.000412	0.00164	CcSEcCtD
Terazosin—Oedema—Paclitaxel—ovarian cancer	0.00041	0.00163	CcSEcCtD
Terazosin—Anaphylactic shock—Paclitaxel—ovarian cancer	0.00041	0.00163	CcSEcCtD
Terazosin—Shock—Paclitaxel—ovarian cancer	0.000403	0.00161	CcSEcCtD
Terazosin—Dizziness—Vinorelbine—ovarian cancer	0.000403	0.00161	CcSEcCtD
Terazosin—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000403	0.00161	CcSEcCtD
Terazosin—Hypokalaemia—Doxorubicin—ovarian cancer	0.000402	0.0016	CcSEcCtD
Terazosin—Angina pectoris—Epirubicin—ovarian cancer	0.000401	0.0016	CcSEcCtD
Terazosin—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000401	0.0016	CcSEcCtD
Terazosin—Tachycardia—Paclitaxel—ovarian cancer	0.0004	0.00159	CcSEcCtD
Terazosin—Bronchitis—Epirubicin—ovarian cancer	0.000396	0.00158	CcSEcCtD
Terazosin—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000396	0.00158	CcSEcCtD
Terazosin—Nasopharyngitis—Doxorubicin—ovarian cancer	0.000395	0.00157	CcSEcCtD
Terazosin—Anorexia—Paclitaxel—ovarian cancer	0.000391	0.00156	CcSEcCtD
Terazosin—Gastritis—Doxorubicin—ovarian cancer	0.00039	0.00156	CcSEcCtD
Terazosin—Vomiting—Vinorelbine—ovarian cancer	0.000388	0.00154	CcSEcCtD
Terazosin—Dysuria—Epirubicin—ovarian cancer	0.000385	0.00154	CcSEcCtD
Terazosin—Rash—Vinorelbine—ovarian cancer	0.000384	0.00153	CcSEcCtD
Terazosin—Dermatitis—Vinorelbine—ovarian cancer	0.000384	0.00153	CcSEcCtD
Terazosin—Hypotension—Paclitaxel—ovarian cancer	0.000383	0.00153	CcSEcCtD
Terazosin—Headache—Vinorelbine—ovarian cancer	0.000382	0.00152	CcSEcCtD
Terazosin—Syncope—Docetaxel—ovarian cancer	0.000382	0.00152	CcSEcCtD
Terazosin—Asthma—Doxorubicin—ovarian cancer	0.000381	0.00152	CcSEcCtD
Terazosin—Influenza—Doxorubicin—ovarian cancer	0.000381	0.00152	CcSEcCtD
Terazosin—Pollakiuria—Epirubicin—ovarian cancer	0.000381	0.00152	CcSEcCtD
Terazosin—Palpitations—Docetaxel—ovarian cancer	0.000376	0.0015	CcSEcCtD
Terazosin—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000376	0.0015	CcSEcCtD
Terazosin—Weight increased—Epirubicin—ovarian cancer	0.000375	0.00149	CcSEcCtD
Terazosin—Loss of consciousness—Docetaxel—ovarian cancer	0.000374	0.00149	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000373	0.00149	CcSEcCtD
Terazosin—Cough—Docetaxel—ovarian cancer	0.000372	0.00148	CcSEcCtD
Terazosin—Angina pectoris—Doxorubicin—ovarian cancer	0.000371	0.00148	CcSEcCtD
Terazosin—Insomnia—Paclitaxel—ovarian cancer	0.000371	0.00148	CcSEcCtD
Terazosin—ABCB1—epithelium—ovarian cancer	0.00037	0.0175	CbGeAlD
Terazosin—Convulsion—Docetaxel—ovarian cancer	0.000369	0.00147	CcSEcCtD
Terazosin—Paraesthesia—Paclitaxel—ovarian cancer	0.000368	0.00147	CcSEcCtD
Terazosin—ABCB1—uterine cervix—ovarian cancer	0.000367	0.0174	CbGeAlD
Terazosin—Bronchitis—Doxorubicin—ovarian cancer	0.000367	0.00146	CcSEcCtD
Terazosin—KCNH2—lymph node—ovarian cancer	0.000367	0.0174	CbGeAlD
Terazosin—Dyspnoea—Paclitaxel—ovarian cancer	0.000365	0.00146	CcSEcCtD
Terazosin—Somnolence—Paclitaxel—ovarian cancer	0.000364	0.00145	CcSEcCtD
Terazosin—Myalgia—Docetaxel—ovarian cancer	0.000362	0.00144	CcSEcCtD
Terazosin—Arthralgia—Docetaxel—ovarian cancer	0.000362	0.00144	CcSEcCtD
Terazosin—Chest pain—Docetaxel—ovarian cancer	0.000362	0.00144	CcSEcCtD
Terazosin—Nausea—Vinorelbine—ovarian cancer	0.000362	0.00144	CcSEcCtD
Terazosin—Dyspepsia—Paclitaxel—ovarian cancer	0.000361	0.00144	CcSEcCtD
Terazosin—Jaundice—Epirubicin—ovarian cancer	0.000358	0.00143	CcSEcCtD
Terazosin—Conjunctivitis—Epirubicin—ovarian cancer	0.000357	0.00142	CcSEcCtD
Terazosin—Urinary tract infection—Epirubicin—ovarian cancer	0.000357	0.00142	CcSEcCtD
Terazosin—Dysuria—Doxorubicin—ovarian cancer	0.000357	0.00142	CcSEcCtD
Terazosin—Decreased appetite—Paclitaxel—ovarian cancer	0.000356	0.00142	CcSEcCtD
Terazosin—Dry mouth—Docetaxel—ovarian cancer	0.000354	0.00141	CcSEcCtD
Terazosin—Fatigue—Paclitaxel—ovarian cancer	0.000353	0.00141	CcSEcCtD
Terazosin—Sweating—Epirubicin—ovarian cancer	0.000352	0.0014	CcSEcCtD
Terazosin—Pollakiuria—Doxorubicin—ovarian cancer	0.000352	0.0014	CcSEcCtD
Terazosin—Pain—Paclitaxel—ovarian cancer	0.000351	0.0014	CcSEcCtD
Terazosin—Constipation—Paclitaxel—ovarian cancer	0.000351	0.0014	CcSEcCtD
Terazosin—Confusional state—Docetaxel—ovarian cancer	0.00035	0.0014	CcSEcCtD
Terazosin—ABCB1—decidua—ovarian cancer	0.00035	0.0166	CbGeAlD
Terazosin—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000348	0.00139	CcSEcCtD
Terazosin—Oedema—Docetaxel—ovarian cancer	0.000347	0.00138	CcSEcCtD
Terazosin—Anaphylactic shock—Docetaxel—ovarian cancer	0.000347	0.00138	CcSEcCtD
Terazosin—Weight increased—Doxorubicin—ovarian cancer	0.000347	0.00138	CcSEcCtD
Terazosin—Epistaxis—Epirubicin—ovarian cancer	0.000347	0.00138	CcSEcCtD
Terazosin—Sinusitis—Epirubicin—ovarian cancer	0.000345	0.00137	CcSEcCtD
Terazosin—Shock—Docetaxel—ovarian cancer	0.000342	0.00136	CcSEcCtD
Terazosin—Thrombocytopenia—Docetaxel—ovarian cancer	0.00034	0.00136	CcSEcCtD
Terazosin—Tachycardia—Docetaxel—ovarian cancer	0.000339	0.00135	CcSEcCtD
Terazosin—Feeling abnormal—Paclitaxel—ovarian cancer	0.000338	0.00135	CcSEcCtD
Terazosin—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000335	0.00134	CcSEcCtD
Terazosin—ABCB1—endometrium—ovarian cancer	0.000332	0.0157	CbGeAlD
Terazosin—Jaundice—Doxorubicin—ovarian cancer	0.000331	0.00132	CcSEcCtD
Terazosin—Anorexia—Docetaxel—ovarian cancer	0.000331	0.00132	CcSEcCtD
Terazosin—Rhinitis—Epirubicin—ovarian cancer	0.000331	0.00132	CcSEcCtD
Terazosin—Conjunctivitis—Doxorubicin—ovarian cancer	0.00033	0.00132	CcSEcCtD
Terazosin—Urinary tract infection—Doxorubicin—ovarian cancer	0.00033	0.00132	CcSEcCtD
Terazosin—Pharyngitis—Epirubicin—ovarian cancer	0.000327	0.0013	CcSEcCtD
Terazosin—Sweating—Doxorubicin—ovarian cancer	0.000326	0.0013	CcSEcCtD
Terazosin—Oedema peripheral—Epirubicin—ovarian cancer	0.000325	0.00129	CcSEcCtD
Terazosin—Hypotension—Docetaxel—ovarian cancer	0.000325	0.00129	CcSEcCtD
Terazosin—Abdominal pain—Paclitaxel—ovarian cancer	0.000324	0.00129	CcSEcCtD
Terazosin—Body temperature increased—Paclitaxel—ovarian cancer	0.000324	0.00129	CcSEcCtD
Terazosin—Epistaxis—Doxorubicin—ovarian cancer	0.000321	0.00128	CcSEcCtD
Terazosin—Sinusitis—Doxorubicin—ovarian cancer	0.000319	0.00127	CcSEcCtD
Terazosin—Visual impairment—Epirubicin—ovarian cancer	0.000318	0.00127	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000317	0.00126	CcSEcCtD
Terazosin—Insomnia—Docetaxel—ovarian cancer	0.000314	0.00125	CcSEcCtD
Terazosin—Paraesthesia—Docetaxel—ovarian cancer	0.000312	0.00124	CcSEcCtD
Terazosin—Dyspnoea—Docetaxel—ovarian cancer	0.00031	0.00123	CcSEcCtD
Terazosin—Somnolence—Docetaxel—ovarian cancer	0.000309	0.00123	CcSEcCtD
Terazosin—Eye disorder—Epirubicin—ovarian cancer	0.000308	0.00123	CcSEcCtD
Terazosin—ABCB1—gonad—ovarian cancer	0.000308	0.0146	CbGeAlD
Terazosin—Tinnitus—Epirubicin—ovarian cancer	0.000308	0.00123	CcSEcCtD
Terazosin—Rhinitis—Doxorubicin—ovarian cancer	0.000306	0.00122	CcSEcCtD
Terazosin—ABCB1—uterus—ovarian cancer	0.000306	0.0145	CbGeAlD
Terazosin—Dyspepsia—Docetaxel—ovarian cancer	0.000306	0.00122	CcSEcCtD
Terazosin—Pharyngitis—Doxorubicin—ovarian cancer	0.000303	0.00121	CcSEcCtD
Terazosin—Decreased appetite—Docetaxel—ovarian cancer	0.000302	0.0012	CcSEcCtD
Terazosin—Hypersensitivity—Paclitaxel—ovarian cancer	0.000302	0.0012	CcSEcCtD
Terazosin—Oedema peripheral—Doxorubicin—ovarian cancer	0.000301	0.0012	CcSEcCtD
Terazosin—Fatigue—Docetaxel—ovarian cancer	0.0003	0.00119	CcSEcCtD
Terazosin—Constipation—Docetaxel—ovarian cancer	0.000297	0.00118	CcSEcCtD
Terazosin—Pain—Docetaxel—ovarian cancer	0.000297	0.00118	CcSEcCtD
Terazosin—Arrhythmia—Epirubicin—ovarian cancer	0.000295	0.00117	CcSEcCtD
Terazosin—Visual impairment—Doxorubicin—ovarian cancer	0.000294	0.00117	CcSEcCtD
Terazosin—Asthenia—Paclitaxel—ovarian cancer	0.000294	0.00117	CcSEcCtD
Terazosin—Pruritus—Paclitaxel—ovarian cancer	0.00029	0.00116	CcSEcCtD
Terazosin—Malnutrition—Epirubicin—ovarian cancer	0.000287	0.00114	CcSEcCtD
Terazosin—Feeling abnormal—Docetaxel—ovarian cancer	0.000286	0.00114	CcSEcCtD
Terazosin—Eye disorder—Doxorubicin—ovarian cancer	0.000285	0.00114	CcSEcCtD
Terazosin—Tinnitus—Doxorubicin—ovarian cancer	0.000285	0.00113	CcSEcCtD
Terazosin—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000284	0.00113	CcSEcCtD
Terazosin—Flatulence—Epirubicin—ovarian cancer	0.000283	0.00113	CcSEcCtD
Terazosin—Tension—Epirubicin—ovarian cancer	0.000282	0.00112	CcSEcCtD
Terazosin—Dysgeusia—Epirubicin—ovarian cancer	0.000281	0.00112	CcSEcCtD
Terazosin—Diarrhoea—Paclitaxel—ovarian cancer	0.00028	0.00112	CcSEcCtD
Terazosin—Nervousness—Epirubicin—ovarian cancer	0.000279	0.00111	CcSEcCtD
Terazosin—Back pain—Epirubicin—ovarian cancer	0.000278	0.00111	CcSEcCtD
Terazosin—ABCB1—female reproductive system—ovarian cancer	0.000275	0.013	CbGeAlD
Terazosin—Body temperature increased—Docetaxel—ovarian cancer	0.000275	0.00109	CcSEcCtD
Terazosin—Abdominal pain—Docetaxel—ovarian cancer	0.000275	0.00109	CcSEcCtD
Terazosin—Arrhythmia—Doxorubicin—ovarian cancer	0.000273	0.00109	CcSEcCtD
Terazosin—Dizziness—Paclitaxel—ovarian cancer	0.000271	0.00108	CcSEcCtD
Terazosin—Vision blurred—Epirubicin—ovarian cancer	0.000271	0.00108	CcSEcCtD
Terazosin—Ill-defined disorder—Epirubicin—ovarian cancer	0.000266	0.00106	CcSEcCtD
Terazosin—Malnutrition—Doxorubicin—ovarian cancer	0.000266	0.00106	CcSEcCtD
Terazosin—Flatulence—Doxorubicin—ovarian cancer	0.000262	0.00104	CcSEcCtD
Terazosin—Tension—Doxorubicin—ovarian cancer	0.000261	0.00104	CcSEcCtD
Terazosin—Vomiting—Paclitaxel—ovarian cancer	0.000261	0.00104	CcSEcCtD
Terazosin—Dysgeusia—Doxorubicin—ovarian cancer	0.00026	0.00104	CcSEcCtD
Terazosin—ABCB1—bone marrow—ovarian cancer	0.00026	0.0123	CbGeAlD
Terazosin—Malaise—Epirubicin—ovarian cancer	0.000259	0.00103	CcSEcCtD
Terazosin—Rash—Paclitaxel—ovarian cancer	0.000258	0.00103	CcSEcCtD
Terazosin—Dermatitis—Paclitaxel—ovarian cancer	0.000258	0.00103	CcSEcCtD
Terazosin—Nervousness—Doxorubicin—ovarian cancer	0.000258	0.00103	CcSEcCtD
Terazosin—Vertigo—Epirubicin—ovarian cancer	0.000258	0.00103	CcSEcCtD
Terazosin—Syncope—Epirubicin—ovarian cancer	0.000258	0.00103	CcSEcCtD
Terazosin—Back pain—Doxorubicin—ovarian cancer	0.000257	0.00102	CcSEcCtD
Terazosin—Headache—Paclitaxel—ovarian cancer	0.000257	0.00102	CcSEcCtD
Terazosin—Hypersensitivity—Docetaxel—ovarian cancer	0.000256	0.00102	CcSEcCtD
Terazosin—Palpitations—Epirubicin—ovarian cancer	0.000254	0.00101	CcSEcCtD
Terazosin—Loss of consciousness—Epirubicin—ovarian cancer	0.000252	0.00101	CcSEcCtD
Terazosin—Cough—Epirubicin—ovarian cancer	0.000251	0.000998	CcSEcCtD
Terazosin—Vision blurred—Doxorubicin—ovarian cancer	0.00025	0.000998	CcSEcCtD
Terazosin—ABCB1—female gonad—ovarian cancer	0.00025	0.0118	CbGeAlD
Terazosin—Asthenia—Docetaxel—ovarian cancer	0.000249	0.000993	CcSEcCtD
Terazosin—Convulsion—Epirubicin—ovarian cancer	0.000249	0.000991	CcSEcCtD
Terazosin—ABCB1—vagina—ovarian cancer	0.000249	0.0118	CbGeAlD
Terazosin—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000247	0.000982	CcSEcCtD
Terazosin—Pruritus—Docetaxel—ovarian cancer	0.000246	0.000979	CcSEcCtD
Terazosin—Arthralgia—Epirubicin—ovarian cancer	0.000244	0.000974	CcSEcCtD
Terazosin—Chest pain—Epirubicin—ovarian cancer	0.000244	0.000974	CcSEcCtD
Terazosin—Myalgia—Epirubicin—ovarian cancer	0.000244	0.000974	CcSEcCtD
Terazosin—Anxiety—Epirubicin—ovarian cancer	0.000244	0.000971	CcSEcCtD
Terazosin—Nausea—Paclitaxel—ovarian cancer	0.000243	0.00097	CcSEcCtD
Terazosin—Discomfort—Epirubicin—ovarian cancer	0.000242	0.000962	CcSEcCtD
Terazosin—Malaise—Doxorubicin—ovarian cancer	0.00024	0.000955	CcSEcCtD
Terazosin—Dry mouth—Epirubicin—ovarian cancer	0.000239	0.000953	CcSEcCtD
Terazosin—Vertigo—Doxorubicin—ovarian cancer	0.000239	0.000951	CcSEcCtD
Terazosin—Syncope—Doxorubicin—ovarian cancer	0.000238	0.000949	CcSEcCtD
Terazosin—Diarrhoea—Docetaxel—ovarian cancer	0.000238	0.000947	CcSEcCtD
Terazosin—Confusional state—Epirubicin—ovarian cancer	0.000236	0.000941	CcSEcCtD
Terazosin—Palpitations—Doxorubicin—ovarian cancer	0.000235	0.000935	CcSEcCtD
Terazosin—Anaphylactic shock—Epirubicin—ovarian cancer	0.000234	0.000934	CcSEcCtD
Terazosin—Oedema—Epirubicin—ovarian cancer	0.000234	0.000934	CcSEcCtD
Terazosin—Loss of consciousness—Doxorubicin—ovarian cancer	0.000234	0.00093	CcSEcCtD
Terazosin—Cough—Doxorubicin—ovarian cancer	0.000232	0.000924	CcSEcCtD
Terazosin—Shock—Epirubicin—ovarian cancer	0.000231	0.000919	CcSEcCtD
Terazosin—Convulsion—Doxorubicin—ovarian cancer	0.00023	0.000917	CcSEcCtD
Terazosin—Dizziness—Docetaxel—ovarian cancer	0.00023	0.000915	CcSEcCtD
Terazosin—Thrombocytopenia—Epirubicin—ovarian cancer	0.000229	0.000914	CcSEcCtD
Terazosin—Tachycardia—Epirubicin—ovarian cancer	0.000229	0.000911	CcSEcCtD
Terazosin—Hyperhidrosis—Epirubicin—ovarian cancer	0.000227	0.000903	CcSEcCtD
Terazosin—Arthralgia—Doxorubicin—ovarian cancer	0.000226	0.000901	CcSEcCtD
Terazosin—Chest pain—Doxorubicin—ovarian cancer	0.000226	0.000901	CcSEcCtD
Terazosin—Myalgia—Doxorubicin—ovarian cancer	0.000226	0.000901	CcSEcCtD
Terazosin—Anxiety—Doxorubicin—ovarian cancer	0.000225	0.000898	CcSEcCtD
Terazosin—Discomfort—Doxorubicin—ovarian cancer	0.000223	0.00089	CcSEcCtD
Terazosin—Anorexia—Epirubicin—ovarian cancer	0.000223	0.00089	CcSEcCtD
Terazosin—ABCB1—testis—ovarian cancer	0.000222	0.0105	CbGeAlD
Terazosin—Dry mouth—Doxorubicin—ovarian cancer	0.000221	0.000881	CcSEcCtD
Terazosin—Vomiting—Docetaxel—ovarian cancer	0.000221	0.00088	CcSEcCtD
Terazosin—Rash—Docetaxel—ovarian cancer	0.000219	0.000873	CcSEcCtD
Terazosin—Hypotension—Epirubicin—ovarian cancer	0.000219	0.000872	CcSEcCtD
Terazosin—Dermatitis—Docetaxel—ovarian cancer	0.000219	0.000872	CcSEcCtD
Terazosin—Confusional state—Doxorubicin—ovarian cancer	0.000219	0.000871	CcSEcCtD
Terazosin—Headache—Docetaxel—ovarian cancer	0.000218	0.000867	CcSEcCtD
Terazosin—Oedema—Doxorubicin—ovarian cancer	0.000217	0.000864	CcSEcCtD
Terazosin—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000217	0.000864	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000214	0.000851	CcSEcCtD
Terazosin—Shock—Doxorubicin—ovarian cancer	0.000213	0.00085	CcSEcCtD
Terazosin—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000212	0.000846	CcSEcCtD
Terazosin—Insomnia—Epirubicin—ovarian cancer	0.000212	0.000844	CcSEcCtD
Terazosin—Tachycardia—Doxorubicin—ovarian cancer	0.000212	0.000843	CcSEcCtD
Terazosin—Paraesthesia—Epirubicin—ovarian cancer	0.00021	0.000838	CcSEcCtD
Terazosin—Hyperhidrosis—Doxorubicin—ovarian cancer	0.00021	0.000835	CcSEcCtD
Terazosin—Dyspnoea—Epirubicin—ovarian cancer	0.000209	0.000832	CcSEcCtD
Terazosin—Somnolence—Epirubicin—ovarian cancer	0.000208	0.00083	CcSEcCtD
Terazosin—Anorexia—Doxorubicin—ovarian cancer	0.000207	0.000823	CcSEcCtD
Terazosin—Nausea—Docetaxel—ovarian cancer	0.000206	0.000822	CcSEcCtD
Terazosin—Dyspepsia—Epirubicin—ovarian cancer	0.000206	0.000822	CcSEcCtD
Terazosin—Decreased appetite—Epirubicin—ovarian cancer	0.000204	0.000812	CcSEcCtD
Terazosin—Hypotension—Doxorubicin—ovarian cancer	0.000203	0.000807	CcSEcCtD
Terazosin—Fatigue—Epirubicin—ovarian cancer	0.000202	0.000805	CcSEcCtD
Terazosin—Constipation—Epirubicin—ovarian cancer	0.0002	0.000798	CcSEcCtD
Terazosin—Pain—Epirubicin—ovarian cancer	0.0002	0.000798	CcSEcCtD
Terazosin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000198	0.000787	CcSEcCtD
Terazosin—Insomnia—Doxorubicin—ovarian cancer	0.000196	0.000781	CcSEcCtD
Terazosin—Paraesthesia—Doxorubicin—ovarian cancer	0.000195	0.000776	CcSEcCtD
Terazosin—Dyspnoea—Doxorubicin—ovarian cancer	0.000193	0.00077	CcSEcCtD
Terazosin—Feeling abnormal—Epirubicin—ovarian cancer	0.000193	0.000769	CcSEcCtD
Terazosin—Somnolence—Doxorubicin—ovarian cancer	0.000193	0.000768	CcSEcCtD
Terazosin—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000192	0.000763	CcSEcCtD
Terazosin—Dyspepsia—Doxorubicin—ovarian cancer	0.000191	0.00076	CcSEcCtD
Terazosin—Decreased appetite—Doxorubicin—ovarian cancer	0.000189	0.000751	CcSEcCtD
Terazosin—Fatigue—Doxorubicin—ovarian cancer	0.000187	0.000745	CcSEcCtD
Terazosin—Pain—Doxorubicin—ovarian cancer	0.000185	0.000739	CcSEcCtD
Terazosin—Constipation—Doxorubicin—ovarian cancer	0.000185	0.000739	CcSEcCtD
Terazosin—Abdominal pain—Epirubicin—ovarian cancer	0.000185	0.000738	CcSEcCtD
Terazosin—Body temperature increased—Epirubicin—ovarian cancer	0.000185	0.000738	CcSEcCtD
Terazosin—Feeling abnormal—Doxorubicin—ovarian cancer	0.000179	0.000712	CcSEcCtD
Terazosin—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000177	0.000706	CcSEcCtD
Terazosin—Hypersensitivity—Epirubicin—ovarian cancer	0.000173	0.000688	CcSEcCtD
Terazosin—Body temperature increased—Doxorubicin—ovarian cancer	0.000171	0.000683	CcSEcCtD
Terazosin—Abdominal pain—Doxorubicin—ovarian cancer	0.000171	0.000683	CcSEcCtD
Terazosin—Asthenia—Epirubicin—ovarian cancer	0.000168	0.00067	CcSEcCtD
Terazosin—Pruritus—Epirubicin—ovarian cancer	0.000166	0.000661	CcSEcCtD
Terazosin—ABCB1—lymph node—ovarian cancer	0.000161	0.00762	CbGeAlD
Terazosin—Diarrhoea—Epirubicin—ovarian cancer	0.00016	0.000639	CcSEcCtD
Terazosin—Hypersensitivity—Doxorubicin—ovarian cancer	0.00016	0.000636	CcSEcCtD
Terazosin—Asthenia—Doxorubicin—ovarian cancer	0.000156	0.00062	CcSEcCtD
Terazosin—Dizziness—Epirubicin—ovarian cancer	0.000155	0.000617	CcSEcCtD
Terazosin—Pruritus—Doxorubicin—ovarian cancer	0.000153	0.000611	CcSEcCtD
Terazosin—Vomiting—Epirubicin—ovarian cancer	0.000149	0.000594	CcSEcCtD
Terazosin—Diarrhoea—Doxorubicin—ovarian cancer	0.000148	0.000591	CcSEcCtD
Terazosin—Rash—Epirubicin—ovarian cancer	0.000148	0.000589	CcSEcCtD
Terazosin—Dermatitis—Epirubicin—ovarian cancer	0.000148	0.000588	CcSEcCtD
Terazosin—Headache—Epirubicin—ovarian cancer	0.000147	0.000585	CcSEcCtD
Terazosin—Dizziness—Doxorubicin—ovarian cancer	0.000143	0.000571	CcSEcCtD
Terazosin—Nausea—Epirubicin—ovarian cancer	0.000139	0.000555	CcSEcCtD
Terazosin—Vomiting—Doxorubicin—ovarian cancer	0.000138	0.000549	CcSEcCtD
Terazosin—Rash—Doxorubicin—ovarian cancer	0.000137	0.000545	CcSEcCtD
Terazosin—Dermatitis—Doxorubicin—ovarian cancer	0.000137	0.000544	CcSEcCtD
Terazosin—Headache—Doxorubicin—ovarian cancer	0.000136	0.000541	CcSEcCtD
Terazosin—Nausea—Doxorubicin—ovarian cancer	0.000129	0.000513	CcSEcCtD
